rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Suven Pharmaceuticals Ltd - Un-Audited Standalone And Consolidated Financial Results For The Quarter And Half-Year Ended 30Th September, 2021
Download announcement < Back
06 Nov 2021
With reference to the above subject, pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of the company, at its meeting held today i.e. November 6, 2021, has taken on record and approved the Un-Audited Standalone and Consolidated Financial Results prepared under Ind AS along with Limited Review Reports of the Statutory Auditors for the quarter and half-year ended 30th September, 2021.&lt;BR&gt; &lt;BR&gt; We are enclosing herewith the following documents:&lt;BR&gt; 1) Un-audited Standalone and Consolidated Financial Results for the quarter and half-year ended 30th September, 2021&lt;BR&gt; 2) Limited Review Reports on the financial results as mentioned above and&lt;BR&gt; 3) A copy of the News Release of our company&lt;BR&gt; &lt;BR&gt; We request you to take these documents on your records. The Board Meeting commenced at 11:30 A.M. and concluded at 12:30 P.M.
View all announcements for Suven Pharmaceuticals Ltd Source: BSE India